Veronica Guerra

Lenalidomide promotes the development of <i>TP53</i>-mutated therapy-related myeloid neoplasms

Adam S. Sperling, Veronica Guerra, James A. Kennedy et al. · Blood · 2022 · 139 citations · Full text

Medicine, Hematology, Oncology +17

Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 Inhibitors

Ahmad S. Alotaibi, Musa Yılmaz, Rashmi Kanagal‐Shamanna et al. · Blood Cancer Discovery · 2020 · 97 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome

Mahesh Swaminathan, Hagop M. Kantarjian, Mark J. Levis et al. · Haematologica · 2021 · 49 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses

Courtney D. DiNardo, Divij Verma, Natalia Baran et al. · Nature Cancer · 2024 · 36 citations

Medicine, Pharmacology, Pharmacotherapy +5

Increased Farnesyltransferase Activity in Human Colorectal Cancer: Relationship with Clinicopathological Features and K-ras Mutation

Mariangela Caruso, Maria Notarnicola, Maurizio Bifulco et al. · Scandinavian Journal of Gastroenterology · 2003 · 16 citations

Medicine, Genetics, Oncology +15